Drug intelligence / Profile preview

CU Xiu Tang

Development stage: Unknown
Lead developer: Eye and ENT Hospital of Fudan University
Administration: Oral

Overview

CU Xiu Tang is a Traditional Chinese Medicine (TCM) decoction developed by the Eye & ENT Hospital of Fudan University for the treatment of olfactory dysfunction. It is primarily investigated as a combination therapy alongside olfactory training to enhance the recovery of smell in patients suffering from post-viral or idiopathic olfactory loss. As a multi-component herbal formula, it is designed to modulate the microenvironment of the olfactory mucosa and potentially promote the regeneration of olfactory sensory neurons. Clinical evaluation has been conducted through randomized controlled trials to assess its efficacy in improving olfactory scores compared to standard olfactory training alone.

Brand names: CU Xiu Tang
Other names: Cu Xiu TangCuxiu Tang促嗅汤

Beyond the preview

Go deeper on CU Xiu Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CU Xiu Tang.

Explore the full profile